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A rapid and sensitive procedure for the estimation of f8-lactam antibiotics is
described which makes use of the ability of these antibiotics to inactivate the R39
DD-carboxypeptidase. Depending on the values of the kinetic parameters which
govern the reaction, the antibiotics fall into two groups. The lower limit for the
quantitative estimation of the antibiotics of groups I and II is about 5 and 50
pmol/ml, respectively. The procedure has been adapted to biological fluids such
as human sera and cows' milk.
/B-Lactam antibiotics can be estimated by var-
ious procedures. The microbiological (agar dif-
fusion) technique (2, 3, 11) permits detection of
about 0.1 to 0.5 ,ug of antibiotic per ml, but it is
time consg. Chemical procedures (9) are
faster but much less sensitive. High-pressure
liquid chromatography has been used to esti-
mate amoxycillin and ampicillin in sera and
urines (12) and cephalosporin C in fermentation
media (1); minimal concentrations of 0.5 Mug of
antibiotic per ml are necessary. Finally, an en-
zyme immunoassay (8) has been devised which
detects ampicillin at concentrations as low as 10
ng/ml; f-lactam antibiotics other than ampicil-
lin, however, were not investigated by this tech-
nique. The present report describes an enzy-
matic method through which /-lactam antibi-
otics in nanogram amounts can be rapidly esti-
mated. The method makes use of the ability of
,B-lactam antibiotics to inactivate the 53,000-dal-
ton R39 DD-carboxypeptidase and rests upon the
determination of the residual enzyme activity
after interaction with the antibiotic.
Theoretical background. The R39 enzyme
(E) reacts with f)-lactam antibiotics (I) according
totheformula: E + It EI-k3E 4 E
+ P(s),where P(s) represents the degradation
product(s) arising from the antibiotics, K is the
dissociation constant of the first stoichiometric
complex El, EI* is a second complex of high
stability in which both the enzyme and the anti-
biotic molecules are modified, and k3 and k4 are
first-order rate constants (7). The efficacy with
which the antibiotics immobilize the R39 en-
zyme in the forn of complex EI* depends on
both the rate at which complex EI* is formed
and the rate at which complex EI* breaks down.
The degradation step EI* A4 E + P(s), on
the one hand, can be neglected if t4 + t2 << 0.69/
kI4 (where ti is the time of interaction between
the enzyme and the antibiotic and t2 is the time
required for the estimation of the residual en-
zyme activity). With the R39 enzyme and all the
/.?-lactam antibiotics tested so far, the k4 term of
the reaction is very low (4 s-- 3 x 10-5 s-l) So
that breakdown of complex EI* has no effect on
the quantitation of the antibiotic if t4 + t2 <<400
min (or more), a condition which is easily ful-
filled. The rate of formation of complex EI*, on
the other hand, is governed by the ratio k3[I]/K
(if [I] < K, which is always the case). In this
respect, the fi-lactam antibiotics which have
been studied fall into two groups (4, 7). The
antibiotics of group I (ampicillin, benzylpenicil-
ln, phenoxymethylpenicillin, cephalosporin C,
cephaloglycine, and cephalothin) characterize
themselves by very high kI3/K values (250,000
M-1 s-' at 37° C). The antibiotics of group fl
(carbenicillin, methicillin, oxacillin, cloxacillin,
and cephalexin) characterize themselves by
moderate k3/K values (about 5,000 M' s'- at
37° C). Antibiotics of groups I and II will be
examined separately (see below).
MATERIALS AND METHODS
Enzymes and coenzyme. The R39 enzyme (mo-
lecular weight, 53,000 t 1,000) was prepared as de-
scribed previously (6) or purchased from UCB Bio-
products, Brussels, Belgium. Horseradish peroxidase,
D-amino acid oxidase, and flavin adenine dinucleotide
were purchased from Boehringer, Mannheim, West
Germany. Rennet (in solution) was from Federa, Brus-
sels.
Substrate. N1,NV-Diacetyl-L-lysyl-D-alanyl-D-ala-
nine (Ac2-L-Lys-D-Ala-D-Ala) was obtained from UCB.
Reagents. o-Dianisidine was from E. Merck AG,
Darmstadt, West Germany (no. 2953), and o-dianisi-
dine sulphate was a gift from P.E. Reynolds, Depart-
ment of Biochenistry, Cambridge, United Kingdom.
Merckoquant-peroxide strips (no. 10011) were from
Merck.
p8-Lactam antibiotics. Benzylpenicillin was ob-
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tained from Rh6ne-Poulenc, Paris, France, or from
UCB; ampicillin and oxacillin were from Bristol Ben-
elux S.A., Brussels; carbenicillin, cloxacillin, methicil-
lin, and amoxycillin were from Beecham Research
Laboratories, Brentford, United Kingdom; and ceph-
alothin, cephalosporin C, cephaloglycine, and cepha-
lexin were from Eli Lilly and Co., Indianapolis, Ind.
Phenoxymethylpenicillin was a gift from H. Vander-
haeghe, K.U. L., Leuven, Belgium.
Estimation of residual enzyme activity. The
reaction catalyzed is Ac2-L-Lys-D-Ala-D-Ala + H20
-- Ac2-L-Lys-D-Ala + D-Ala. The kinetic parameters
are: K,m 0.1 mM; V,m., 19 tmol of tripeptide hydrolyzed
min-' (mg of protein)-'. The released D-alanine was
estimated by the D-amino acid oxidase-peroxidase-o-
dianisidine technique. The free D-alanine is trans-
formed into pyruvate and H202 by the D-amino acid
oxidase-flavin adenine dinucleotide system, and the o-
dianisidine is oxidized by H202 into a chromogenic
compound (at Amax = 460 nm) under the action of the
peroxidase. In some cases, the technique was per-
formed exactly as described previously (5), except that
because of the presence of Mg2+ ions in the reaction
mixtures, the potassium pyrophosphate buffer was
replaced by 0.1 M tris-(hydroxmethyl)aminomethane-
hydrochloride buffer, pH 8.3 (procedure A). In other
cases (procedure B), the procedure was further modi-
fied as follows: (i) a twofold- and a fivefold-increased
amount of D-amino acid oxidase and peroxidase, re-
spectively, were used; (ii) the solution of o-dianisidine
in methanol was replaced by a solution of o-dianisidine
sulphate in water (5 mg/ml); and (iii) a 0.2% sodium
dodecyl sulphate solution in water (300 pi) was used
instead of the methanol-water solution just before
estimating the absorbance of the solution at 460 nm.
Finally, for semiquantitative assays, the amount of
H202 produced from D-alanine by the D-amino acid
oxidase-flavin adenine dinucleotide system was
roughly estimated with the help of Merckoquant-per-
oxide strips.
RESULTS
Estimation of antibiotics of group I in
aqueous solution. The antibiotics of group I,
in amounts ranging between 0.5 and 2.5 pmol,
were estimated by using 2.5 pmol of R39 enzyme
in a final volume of 100 pd of 50 mM N-2-hy-droxyethylpiperazine-N'-2-ethanesulfonic acid
(HEPES) buffer (pH 8.3) containing 0.1 M NaCl
and 5 mM MgCl2. At 370C, formation ofcomplex
EI* was complete within 10 to 15 min. Since Lo
' Eo (where Io and Eo are the concentrations of
antibiotic and enzyme, respectively, at t = 0),
the amount of complex EI* formed is virtually
equal to the amount of Io, i.e., to Eo (1 - A/Ao),
where Ao and A are the initial and residual
enzyme activities, respectively. As an example,
Fig. 1 shows the results obtained with benzyl-
penicillin (for experimental details, see legend to
the figure). The whole operation is achieved in
about 30 min.
A concentration of 5 to 10 pmol (i.e., about 2
to 4 ng) of antibiotic per ml was the lower limit
for quantitative (and rapid) determinations.
However, the technique permits detection of the
antibiotics at much lower concentrations. To
illustrate the high sensitivity of the method, Fig.
2 shows the results obtained with samples con-
taining 0.05 to 0.25 pmol of various antibiotics
(in 100 pi of buffer containing 0.25 pmol of R39enzyme). At these extremely low concentrations,
the assays remain specific but provide only
semiquantitative results. Moreover (see legend
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FIG. 1. Residual DD-carboxypeptidase activity of
the R39 enzyme (0.12 pg) after reaction at 37C with
0.2 to 1.0 ng of benzylpenicillin in 100 tlI of 50 mM
HEPES buffer (pH 8.3) containing 0.1 M NaCI and 5
mM MgCI2. Samples (90 ul) containing 2 to 10 ng of
benzylpenicillin per ml (and 90 ,Al of water used as
control) were supplemented with 10 jil of 500 mMHEPES buffer (pH 8.3) containing 1.0 M NaCl, 50
mMMgC4, and 2.5pmol (i.e., 0.12 pg) ofR39 enzyme
and incubated for 10 min at 37° C. The reaction
mixtures were then supplemented with 75 nmol of
Ac2-L-Lys-D-Ala-D-Ala (5td, in water) and incubated
at37Cfor 10min. The released D-alanine was finally
eliminated by the D-amino acid oxidase-peroxidase-










00 0.05 0.1 ng
[Antibioti c]; ng /100 -y1 buffer
FIG. 2. Residual DD-carboxypeptidase activity of
the R39 enzyme (0.012 ag) after reaction at 37C with
0.02 to 0.1 ng of benzylpenicillin (0), ampicillin (5),
cephalosporin C (0), and phenoxymethylpenicillin(U) in 100 pi of 50 mM HEPES buffer (pH 8.3)containing 0.1 M NaCI and 5 mM MgCI2. The exper-
imental conditions were the same as those described
in the legend to Fig. 1, except that both the time (t,)
of interaction between the enzyme and the antibiotic
and the time (t2) of incubation of the substrate with
the residual enzyme were 90 min (instead of 10 min).
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Estimation! of antibiotics of group I in
human sera and fresh cows' milk. The esti-
mation of antibiotics of group I occurring in
picomole amounts per milliliter ofhuman serum
and cows' milk requ'ires prior treatments of the
fluids. As observed previously (10), low quanti-
ties of control serum (0.5 to 2 td) apparentlyenhance the DD-carboxypeptidase activity ofthe
R39 enzyme, whereas large quantities strongly
inhibit the coupling D-amino acid oxidase-per-
oxidase system. Similarly, the activity ofthe R39
enzyme appears to be strongly inhibited by at
least some milk samples.
Serum samples (50 id) containing 10 to 50pmol of antibiotic per ml (and a serum control
without antibiotic) were supplemented with ace-
tone (100 pl). After stirring, the mixtures were
centrifuged for 15 min at 5,000 rpm, the super-
natant fractions were rapidly evaporated under
vacuum, and the residues were treated as de-
scribed in the legend to Fig. 3. Similar results
were obtained with antibiotics other than ben-
zylpenicillin. A double-blind test was also per-
forned on a series of 30 samples containing from
6 to 20 ng of benzylpenicillin per ml of serum.
The average error was 12%, and the largest
individual error was 34%.
Milk samples containing 25 to 250 pmol of
antibiotic per ml (and a milk control) were sup-
plemented with an equal volume of ethanol.
After elimination of the precipitate by centrifu-
gation, 40-pl samples of the supernatant frac-
tions were evaporated under vacuum, and the
residues were treated as described in the legend
to Fig. 4. Alternatively, the milk samples (1.5
ml) were supplemented with 100 pl of the rennetsolution. Clotting was achieved within 5 min at
37° C. After elimination of the precipitate, 20-p1samples of the supernatant fractions were
treated as described in the legend to Fig. 4.
The usefilness of this method is not confined
to these examples. They are meant to illustrate
how the proposed enzymatic procedure can be
adapted to estimate f8-lactam antibiotics of
group I occurring in sera and milk at concentra-
tions as low as 5 and 25 ng/ml, respectively.
Depending on the antibiotic concentrations and
the precision required, the technique is suscep-
tible to many variations, as shown by the follow-
ing two cases.
Precipitation with acetone of serum samplescontaining 10 to 50 pmol of antibiotic per ml
could be avoided for semiquantitative assays.
Serum samples (50 td) and a serum control weresupplemented wth 50 pl of 100 mM HEPESbuffer (pH 8.5) containing 0.2 M NaCl, 10 mM
MgC12, and 2.5 pmol (i.e., 0.12 pg) ofR39 enzyme.The reaction mix2tures were successively incu-
bated for 20 min at 37° C, supplemented with
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150 nmol of Ac2-L-Lys-D-Ala-D-Ala (5 pl), incu-bated for 30 min at 370C, supplemented with 60
id of a solution containing 10 ng of D-amino acidoxidase and 3 ,ug of flavin adenine dinucleotide
[Benzylpenicillin];ng/50 yI serum
FIG. 3. Estimation of benzylpenicillin in human
serum. Samples (50 1Id) of control serum (without
benzylpenicillin) and ofsera containing 10 to 50pmol
of benzylpenicillin per ml were treated with acetone,and the supernatant fractions were evaporated (see
text). The residues were dissolved in 40 1ll of 50 mMHEPES buffer (pH 8.3) containing 0.1 MNaCl, 5mM
MgC4, and 2.5 pmol (i.e., 0.12 pg) of enzyme. Thereaction mixtures were incubated for 10 min at 37° C,
supplemented with 75nmolofAc2-L-Lys-D-Ala-D-Ala
(51ll), and incubated at 37° C for 10 min. The amount
of D-alanine released was then estimated by the D-






FIG. 4. Estimation of benzylpenicillin in fresh
cows' milk. Samples of control milk (without benzyl-
penicillin) and of milk containing 25 to 250 pmol of
benzylpenicillin per ml were treated either with an
equal volume of ethanol and 40-tld samples of the
supernatant fractions were evaporated (see text), or
with rennet (using 1 vol of rennet solution for 15 vol
of the milk sample) and 20-pl samples of the super-
natant fractions were collected (see text). The dry
residues (after ethanol treatment) (Fig. 4A) and the
20-1 samples (after rennet treatmnent) (Fig. 4B) were
successively (i) supplemented with 30 Il of 50 mMHEPES buffer containing 0.1 M NaCI and 50 mM
MgC12 and then with 10 jld of a solution containing
0.16 Ag of R39 enzyme, (ii) incubated for 10 min at37° C, (iii) supplemented with 75 nmol of AC2-L-Lys-
D-Ala-D-Ala (5 ul), and (iv) incubated for 30 min at
37° C. The released D-alanine was finally estimated
by the D-amino acid oxidase-peroxidase-o-dianisi-
dine technique (procedure B).
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in 0.1 M tris(hydroxymethyl)aminomethane-hy-
drochloride buffer (pH 8.3); and, finally, incu-
bated for 2 min at 370C. A Merckoquant-perox-
ide strip was then immersed in each solution for
2 to 3 s, removed, and maintained at room
temperature for 5 to 10 s. With the control
serum, the strips turned blue-grey. With sera
containing 50 pmol or more of antibiotic per ml,
the strips remained yellow-pink, indicating that
all the enzyme had been immobilized by the
antibiotic in the form of complex EI*. Sera con-
taining less than 50 pmol but at least 10 pmol of
antibiotic per ml gave rise to intermediate col-
orations.
Evaporation of the supematant fractions ob-
tained after acetone precipitation of the serum
samples could be avoided if these samples con-
tained 0.6 to 3.0 nmol (i.e., 0.25 to 1.20 ug) of
antibiotic per ml. Samples (1 to 5 pl) of the
supernatant fractions were diluted to 90 ,ul with
water, and the assays were performed as de-
scribed in the legend to Fig. 1. Quantitative and
reproducible results were obtained.
Estimation of antibiotics of group II.
When compared with the antibiotics of group I,
and as a consequence of the moderate k3/K
values (5,000 M-1 s-1 at 370C), formation of
complex EI* with the antibiotics of group II
should require, to be complete, a 10-fold in-
creased incubation time (t1) between the antibi-
otic and the R39 enzyme. However, since an
upper limit is imposed on t4 by the condition t1
+ t2 s0.69/k4, the lower limit of detection of the
group II antibiotics is, in practice, 10-fold higher.
It thus follows that with the antibiotics of group
II, Io >> Eo and that the reaction is stopped long
before fornation of complex EI* is complete.
Human sera containing 20 to 80 ng of oxacillin,
cloxacillin, or cephalexin, 40 to 200 ng of methi-
cillin, or 80 to 400 ng of carbenicillin per ml were
processed as described in the legend to Fig. 3,
except that the incubation of the antibiotic with
the enzyme was for 30 min, and the subsequent
incubation with Ac2-L-Lys-D-Ala-D-Ala was for





[Cephalexin]; ng/50 ul serum
FIG. 5. Estimation of cephalexin in human serum.
For conditions, see text and legend to Fig. 1.
DISCUSSION
The enzymatic procedure described in this
paper allows the estimation of nanogram
amounts of /4-lactam antibiotics and permits
many simultaneous tests to be carried out in a
short time. It is specific for fi-lactam antibiotics,
and its specificity can be easily checked by
studying the effect of ,B-lactamase action on the
samples to be analyzed. The assay, however,
does not discriminate between various,8-lactam
antibiotics, and its sensitivity for a given antibi-
otic depends on the k3/K value (see above)
which characterizes the interaction between the
R39 enzyme and the antibiotic under consider-
ation. It thus follows that depending on the k3/
K value, the amount of antibiotic or the size of
the sample to be analyzed must be adapted
accordingly. This point has been illustrated by
using antibiotics for which the k3/K value is very
high (250,000 M1 s-') or moderate (about 5,000
M-1 s). Novel 8-lactam compounds such as
mecillinam and clavulanate have very low k3/K
values (30 to 50 M-1 sC at 37° C) (J. Kelly, J. M.
Frere, D. Klein, and J. M. Ghuysen, manuscript
in preparation), so that the sensitivity of the
assay is considerably decreased. In principle,
however, microgram amounts of such com-
pounds could also be estimated. Finally, diffi-
culties may be encountered with complex bio-
logical fluids. The procedure has been applied to
human serum and cow milk. When compared
with the other DD-carboxypeptidases so far iden-
tified, the R39 enzyme characterizes itself by
extremely high k3/K values for many f-lactam
antibiotics and extremely low k4 values for all
the antibiotics tested, which make it especially
suitable for the type of enzymatic assay dis-
cussed here.
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